Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

2013906 citationsJournal Article

Authors

Good health and well-being

Published in: Gastroenterology

Volume 145, Issue 3, pp. 574-582.e1

Field-Weighted Citation Impact: 38.19